Alzamend Neuro’s Phase 1/2A lithium neuroimaging data accepted for poster
Alzamend Neuro’s Phase 1/2A lithium neuroimaging data has been accepted for poster presentation at Neuroscience 2026 in Washington, DC, per TradeXchange Newsdesk.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Alzamend Neuro’s Phase 1/2A lithium neuroimaging data has been accepted for poster presentation at Neuroscience 2026 in Washington, DC, per TradeXchange Newsdesk.